can tirzepatide cause blindness Ozempic-like Drugs Blindness? Their Ophthalmic Complications Explained #DoctorSpeak New diabetes and weight-loss drugs like Semaglutide and (Commonly known as Ozempic, Wegovy) which are GLP1 Agonist Drugs have become more You've seen the headlines. Should

Lets be real: both are expensive (were talking hundreds of dollars per month without insurance)

Accordingly, the initial dose of IcoSema in the phase 3a clinical trials corresponded to a semaglutide dose of 0.114 mg [13,14,15], which is lower than the 0.25 mg starting dose used for semaglutide alone

GLP-1: Key to Blood Glucose Homeostasis GLP-1 is part of a group of metabolic hormones called incretin hormones that help decrease blood glucose levels

Mounjaro (tirzepatide), a dual GLP-1 and GIP receptor agonist, is approved by the MHRA for type 2 diabetes and weight management under specific NICE guidance

it is not approved by the MHRA or EMA